BOTANICAL IDENTITY
The right name is the first step.
Also known as: No synonyms listed.
Check the species, plant part and complete botanical name together. A photograph alone cannot identify a harvest safely for consumption.
An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.
01 · UNDERSTAND
Properties & uses.
Pharmacopoeial material: flower
The listed flower should not be equated with edible leaves in other aibika preparations. This notice infers no therapeutic indication.
Read the sourceProteinuria: a targeted clinical signal
A greater reduction in urinary protein was reported, without significant improvement in kidney filtration. Preparation-specific findings in selected patients; do not generalise to advanced kidney impairment.
Read the sourceThe traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.
02 · UNDERSTAND THE ACTION
How does the plant act?
This reference concerns a defined preparation of Abelmoschus manihot (L.) Medik.. Findings come from participants studied in a specific setting and do not validate every preparation of the plant.
Proteinuria: a targeted clinical signal
Reducing a urinary marker does not establish long-term prevention of kidney failure.
Read the referenceWhat this means for preparation.
Reducing a urinary marker does not establish long-term prevention of kidney failure.
03 · EXAMINE THE EVIDENCE
What the research shows.
A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.
Proteinuria: a targeted clinical signal — 2014
- Type of research
- Open-label multicentre randomised trial in biopsy-confirmed glomerular disease.
- Preparation concerned
- Huangkui capsules, compared with losartan and the combination.
- Observed results
- A greater reduction in urinary protein was reported, without significant improvement in kidney filtration.
- Limitations to consider
- Preparation-specific findings in selected patients; do not generalise to advanced kidney impairment.
What can we take from this?
Preparation-specific findings in selected patients; do not generalise to advanced kidney impairment. Interactions, pregnancy and long-term use require separate assessment.
Documentary review dated 09/10/2026. The references remain available to check the context.
04 · CHOOSE A PREPARATION
One plant, several preparations.
Only forms documented in this profile’s sources are presented.
Studied preparation — documentary referencePart not explicit in the abstract reviewed; do not infer it from the inventory. · Route: not recommended for self-treatment
Huangkui capsules, compared with losartan and the combination.
Please note: Research description only; no self-treatment dose, recipe or duration is offered.
Read the source05 · BEFORE ANY USE
Precautions & contraindications.
This guidance does not cover every individual situation. Missing information is not a guarantee of safety.
Contraindications
- This botanical dossier does not establish medicinal-use safety. Anyone with a medical condition or taking medicine needs professional assessment of the specific product.
Medicine interactions
- Interactions have not been sufficiently assessed in the sources retained for this notice; an incomplete assessment guarantees no compatibility.
Adverse effects
- This notice does not provide a complete adverse-effect assessment. Historical use alone cannot exclude toxicity.
Pregnancy & breastfeeding
No medicinal use is offered during pregnancy or breastfeeding; this dossier cannot establish safety in these situations.
Children & adolescents
No paediatric preparation or dose is offered in this notice.
If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.
06 · PUTTING KNOWLEDGE INTO PRACTICE
Preparations & recipes.
No recipe or home use is recommended in this documentary profile.
07 · CHECK THE SOURCES
Sources for this profile.
- ANSM — French Pharmacopoeia, List A, January 2026, p. 2Accessed on 09/10/2026
- Kew POWO — Abelmoschus manihot (L.) Medik.Accessed on 09/10/2026
- Zhang L et al. (2014) — Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trialAccessed on 09/10/2026
A TOUCH OF SOLÉA
Myriam’s tip
Myriam is reviewing the tip for this profile.
Myriam